UPDATE
Aug 12, 2022, 05.00 PM
The company's EBITDA for the quarter is Rs.(16) crore as compared to Rs.(33) crore in Q4FY22.
The company's EBITDA for the quarter is Rs.(16) crore as compared to Rs.(33) crore in Q4FY22.
Wockhardt Limited, the Pharmaceutical and Biotechnology major, reported its 1st quarter results for Financial Year 2022-23.
The company recorded a revenue of Rs.595 crore in Q1FY23 compared to Rs. 655 crore in previous quarter registering a de-growth of 9%.
The company's EBITDA for the quarter is Rs.(16) crore as compared to Rs.(33) crore in Q4FY22.
The company was granted 1 patent during the quarter and now holds 804 patents.
UP NEXT
Read Next
